[go: up one dir, main page]

ZA200904281B - Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders - Google Patents

Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders

Info

Publication number
ZA200904281B
ZA200904281B ZA200904281A ZA200904281A ZA200904281B ZA 200904281 B ZA200904281 B ZA 200904281B ZA 200904281 A ZA200904281 A ZA 200904281A ZA 200904281 A ZA200904281 A ZA 200904281A ZA 200904281 B ZA200904281 B ZA 200904281B
Authority
ZA
South Africa
Prior art keywords
diabetes
treatment
receptor agonists
metabolic disorders
heterocyclic
Prior art date
Application number
ZA200904281A
Inventor
Xin Chen
Peng Cheng
L Edward Clemens
Jeffrey D Johnson
Jingyuan Ma
Alison Murphy
Imad Nashashibi
Christopher J Rabbat
Jiangao Song
Maria E Wilson
Yan Zhu
Zuchun Zhao
Original Assignee
Metabolex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40261614&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200904281(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Metabolex Inc filed Critical Metabolex Inc
Publication of ZA200904281B publication Critical patent/ZA200904281B/en

Links

ZA200904281A 2006-12-28 2007-12-27 Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders ZA200904281B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87790306P 2006-12-28 2006-12-28

Publications (1)

Publication Number Publication Date
ZA200904281B true ZA200904281B (en) 2010-08-25

Family

ID=40261614

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200904281A ZA200904281B (en) 2006-12-28 2007-12-27 Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders

Country Status (5)

Country Link
CN (1) CN101616586B (en)
AR (1) AR064702A1 (en)
CL (1) CL2007003841A1 (en)
TW (1) TWI414523B (en)
ZA (1) ZA200904281B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7638541B2 (en) 2006-12-28 2009-12-29 Metabolex Inc. 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
CL2009000782A1 (en) * 2008-03-31 2010-04-30 Metabolex Inc Method comprising a substituted oxymethylene aryl derivative compound, dpp-iv inhibitors; and its use in the treatment of diabetes and lowering of triglycerides, among other diseases.
EP2483281B1 (en) 2009-10-01 2014-06-04 Cymabay Therapeutics, Inc. Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts
ES2613066T3 (en) * 2010-04-28 2017-05-22 Bayer Intellectual Property Gmbh Ketoheteroarylpiperidine and -piperazine derivatives as fungicides
BR112012032248A2 (en) * 2010-06-23 2016-09-13 Metabolex Inc 5-ethyl-2- {4 - [- 4- (-4-tetrazol-1-yl-phenoxymethyl) -thiazol-2-yl] -piperidin-1-yl} -pyrimidine compositions
CN103467398B (en) * 2013-09-03 2015-01-21 浙江医药高等专科学校 Triazole amide compounds, and preparation method and application thereof in resisting diabetes
CN112920180A (en) * 2014-01-06 2021-06-08 理森制药股份公司 Glutaminase inhibitors
JP2019527693A (en) 2016-08-03 2019-10-03 サイマベイ・セラピューティクス・インコーポレイテッドＣｙｍａＢａｙ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． Oxymethylene aryl compounds for treating inflammatory gastrointestinal diseases or gastrointestinal conditions
CN111072652B (en) * 2018-10-19 2023-05-23 暨南大学 Compounds for the treatment of diabetes and/or related disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1829718A (en) * 2003-07-14 2006-09-06 艾尼纳制药公司 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
NZ547965A (en) * 2003-12-24 2009-12-24 Prosidion Ltd 1,2,4-Oxadiazole derivatives as GPCR receptor agonists

Also Published As

Publication number Publication date
CN101616586B (en) 2014-08-13
TW200833688A (en) 2008-08-16
AR064702A1 (en) 2009-04-22
TWI414523B (en) 2013-11-11
CL2007003841A1 (en) 2008-03-14
CN101616586A (en) 2009-12-30

Similar Documents

Publication Publication Date Title
BRPI0814294A2 (en) N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders.
ZA200904281B (en) Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
WO2007109135A3 (en) Neuromedin u receptor agonists and uses thereof
IL193070A0 (en) Heterobicyclic sulfonamide derivatives for the treatment of diabetes
EP1976377A4 (en) Compounds for the treatment of metabolic disorders
ZA201008807B (en) Gip-based mixed agonists for treatment of metabolic disorders and obesity
ZA200900734B (en) Combination treatment for metabolic disorders
EP2217073A4 (en) Method of treating metabolic disorders and depression with dopamine receptor agonists
IL195203A0 (en) Compounds for the treatment of metabolic disorders
WO2007100535A3 (en) Oxyntomodulin derivatives
IL205381A0 (en) Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
IL193800A0 (en) Endothelin and endothelin receptor agonists in the treatment of metabolic diseases
IL194189A0 (en) Combination treatment of metabolic disorders
ZA200805645B (en) Compounds for the treatment of metabolic disorders
EP2051732A4 (en) Methods of diagnosis and treatment for metabolic disorders
IL180721A0 (en) Nicotinic receptor agonists for the treatment of inflammatory diseases
IL197695A0 (en) 3-amino-pyridine derivatives for the treatment of metabolic disorders
IL191271A0 (en) Adenosine a3 receptor agonists for the treatment of dry eye disorders
IL195392A0 (en) Compounds for the treatment of metabolic disorders
IL201119A0 (en) Methods and compositions of derivatives of probucol for the treatment of diabetes
IL192851A0 (en) Compounds for the treatment of metabolic disorders
IL195920A0 (en) 3-(1h-indol-3-ydindan-1-ylamine derivatives for the treatment of depression and anxiety
IL192982A0 (en) Compounds for the treatment of metabolic disorders
HK1135690A (en) 3-amino-pyridine derivatives for the treatment of metabolic disorders
HK1124245A (en) Combination treatment of metabolic disorders